
COVIDãã³ãããã¯ãšæ¿åºã®å¯Ÿå¿ã«é¢ãã520ããŒãžã«åã¶äžé¢å ±åæžããã®7ã€ã®èŠç¹
å èšäºã¯ãã¡ããã/Click here to read the original article.
520ããŒãžã«åã¶ãã®å ±åæžã«ã¯ãç±³åœã®å ¬è¡è¡çåœå±ãéç§åŠçãªæ ¹æ ã«åºã¥ããå§åïŒãã¹ã¯ãåäŸã®åŠæ ¡ééãªã©ïŒãè¡ããç±³åœåžæ°ã®æå°è ã«å¯Ÿããä¿¡é Œã䟵害ããäŸãæããããŠããã
æææ¥ã«çºè¡šãããç±³äžé¢ã³ãããŠã€ã«ã¹ãã³ãããã¯ç¹å¥å°å§å¡äŒã®æçµå ±åæžã¯ãç±³åœã®å ¬è¡è¡çã·ã¹ãã ã«ãããé«ã¬ãã«ã®è æãæŽé²ããŠããã
520ããŒãžã«åã¶ãã®å ±åæžã¯ãç±³åœã®å ¬è¡è¡çåœå±è ããéç§åŠçãªæ ¹æ ã«åºã¥ãå§åïŒãã¹ã¯ãåäŸã®åŠæ ¡ééãªã©ïŒãè¡ããç±³åœåžæ°ã®æå°è ã«å¯Ÿããä¿¡é Œã䟵害ããäŸãæããŠããã
ãä¿¡é Œã¯åã¡åããã®ã ããšãå°å§å¡äŒã®å§å¡é·ãåãããã©ããã»ã¬ã³ã¹ãã©ããäžé¢è°å¡ïŒãªãã€ãªå·éžåºïŒã¯è°äŒã«å®ãŠãæžç°¡ã®äžã§æžããŠãããã説æè²¬ä»»ãéææ§ãæ£çŽããèª å®ããããã®ä¿¡é Œãåãæ»ãã®ã§ããå°æ¥ã®ãã³ãããã¯ã«ã¯ãå人çãªå©çãåèŠãæããªã人ã ã«ãã£ãŠç®¡çããããã¢ã¡ãªã«å šäœã®å¯Ÿå¿ãå¿ èŠã§ããã
ãã¬ã¹ãªãªãŒã¹ã«ãããšã2幎ã«ããã調æ»ãçµããã®å ±åæžã¯ãCOVID-19ã®ãã³ãããã¯ã«ããã ãæèš ããç¶²çŸ ããç±³åœæ¿åºãšæ°ééšéãå°æ¥ã®ãã³ãããã¯ã«ããããåãã察å¿ããããã® ãããŒãããã ããšãªã£ãŠããã
ã¬ã³ã¹ãã©ããæ°ã¯ãããã®äœæ¥ãç¶ç¶ããçºå±ããããããšãè°äŒã«ä¿ãããèŠã€ããã¹ãæ å ±ãšåãã¹ãèª å®ãªè¡åããã£ãšããããšææããã
Children's Health DefenseïŒCHDïŒã®ã¡ã¢ãªãŒã»ãã©ã³ãæé«çµå¶è²¬ä»»è ïŒCEOïŒã¯ããDefenderãçŽã«å¯ŸãããCOVIDäžã«èµ·ãã£ãããšã®å æ¬çãªèšé²ãäœæããç¹å¥å°å§å¡äŒã®æŽ»åã«æè¬ããããšè¿°ã¹ãã圌女ã¯ããä»ãå ããïŒ
ãŠã§ã³ã¹ãã«ããå§å¡é·ãè¿°ã¹ãããã«ãããŸã èŠã€ããã¹ãæ å ±ãšåãã¹ãèª å®ãªè¡åããã ããšã¯ããããã®èšå€§ãªå ±åæžã¯ãCOVID-19ã®ç 究宀æµåºã®å¯èœæ§ãNIHïŒåœç«è¡çç ç©¶æïŒãšHHSïŒç±³åœä¿å¥ç€ŸäŒçŠç¥çïŒã®åŠšå®³ãè³éæäŸã®ä»çµã¿ã«ãããäžæ£ã®æšªè¡ããããŠç±³åœã®COVIDæ¿çã«ããåäŸãã¡ãžã®ç°åžžãªè¢«å®³ã«ã€ããŠæŠèª¬ããŠããã
ããã®å ±åæžã¯ãäžçäžã®äžé¢ã食ããã¥ãŒã¹ã«ãªãã¯ãã ã
ã©ã³ãã»ããŒã«äžé¢è°å¡ïŒå ±åïŒã¯ããã®æ°ããå ±åæžã¯ãæŠæŒ¢ã§è¡ãããå±éºãªæ©èœç²åŸç ç©¶ã®ãããªãçšéãæå ¥ãããç ç©¶ã«å¯Ÿããç¬ç«ããç£èŠã確ä¿ããããã«åœŒãæåºããæ³æ¡ã§ããããå±éºç ç©¶å¯©æ»æ³ããè°äŒã坿±ºããªããã°ãªããªãçç±ã«ã€ããŠã®åœŒã®äž»åŒµãè£åŒ·ãããã®ã§ããããšããã£ãã§ã³ããŒãã«èªã£ãã
ããŠã§ã³ã¹ãã©ããå§å¡é·ãææããããã«ãæ¥å¹ŽåºŠããã®å°å§å¡äŒã®ä»äºãåŒãç¶ãã§ããããšãéèŠã§ãããç§ã¯æ¥å¹ŽåºŠãäžé¢åœåå®å šä¿éã»æ¿åºåé¡å°å§å¡äŒã®å§å¡é·ãšããŠããããããšã楜ãã¿ã«ããŠããããšããŒã«ã¯èªã£ãã
æ°Žææ¥ã«ãå§å¡äŒã¯å ±åæžã®æçµããŒã¯ã¢ãããçµããè°äŒèšé²ã«æåºããã
調æ»ã®ããã«ãå§å¡äŒã®ã¡ã³ããŒã¯25åã®å ¬èŽäŒãéãã30å以äžã®ã€ã³ã¿ãã¥ãŒãšå®£èªèšŒèšãè¡ãã100äžããŒãžä»¥äžã®ææžãæ€èšããã
å ±åæžã¯ãCOVID-19ãã³ãããã¯ããããããŸããŸãªåé¡ã«é¢é£ãã100以äžã®èª¿æ»çµæãç¶²çŸ ããŠãããåé¡ã¯COVID-19ã®èµ·æºãããçŽçšè ã®è³éãã©ã®ããã«äœ¿ãããããæ¿åºé¢ä¿è ãã©ã®çšåºŠèª¿æ»ã«ååããããŸã§å€å²ã«ããã£ãã
以äžã¯å ±åæžããã®7ã€ã®ãã€ã©ã€ãã§ããã
1.COVIDãŠã€ã«ã¹ã¯ç 究宀ããã®æµåºã«ãããã®ã§ããå¯èœæ§ãé«ã
COVID-19ã®ãã³ãããã¯ã«æè»ãããããŠã€ã«ã¹ã¯ãäžåœæŠæŒ¢ã®ç ç©¶æã§è¡ãããæ©èœç²åŸç ç©¶ã«ãããã®ã§ããå¯èœæ§ããæãé«ãããšãã¬ã¹ãªãªãŒã¹ã¯è¿°ã¹ãŠããã
è°äŒèª¿æ»å£ã¯ãç 究宀æµåºèª¬ãæ¯æãã5ã€ã®åŒ·åãªè«æ ãæããïŒ
ãŠã€ã«ã¹ã¯èªç¶çã«ã¯ãªãçç©åŠçç¹åŸŽãæã£ãŠããã
ããŒã¿ã«ããã°ãCOVID-19ã®å šçäŸã¯ãããã«æã¡èŸŒãŸãã1ã€ã®ãŠã€ã«ã¹ããçºçããŠããããã®ããšã¯ãéå»ã«æµè¡ãããã³ãããã¯ã§ã¯è€æ°ã®ææçµè·¯ããã£ãããšã«åããŠããã
æŠæŒ¢ã«ã¯äžåœéäžã®SARSç 究宀ããããäžååãªãã€ãªã»ãŒããã£ãŒã¬ãã«ã§æ©èœç²åŸç ç©¶ãè¡ã£ãŠããæŽå²ãããã
æŠæŒ¢ãŠã€ã«ã¹ç ç©¶æïŒWIVïŒã®ç ç©¶è ã¯ãCOVID-19ããŠã§ããããŒã±ããã§çºèŠãããæ°ã«æåã®2019幎ç§ã«COVIDæ§ãŠã€ã«ã¹ã«çœ¹æ£ããŠããã
å ±åæžã«ãããšããŠã€ã«ã¹åŠè ããŒã¿ãŒã»ãã¹ã¶ãã¯æ°ã代衚ãåãããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ã¯ãäžåœæŠæŒ¢ã§ã®æ©èœç²åŸç ç©¶ãä¿é²ããããã«ç±³åœã®çšéã䜿çšãããšããããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ã¯ãå°ãªããšãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æã§ã®æ©èœç²åŸç ç©¶ã«é¢ãããã®ãå«ããæ°çŸäžãã«ãã®çšéãæå ¥ãããNIHè£å©éãåãåã£ãéå¶å©å£äœã§ããã
å ±åæžã¯ãã¢ã³ãœããŒã»ãã¡ãŠãå士ãçããNIHã®åœç«ã¢ã¬ã«ã®ãŒã»ææçç ç©¶æïŒNIAIDïŒããšã³ãã«ã¹ã®ç ç©¶ãç£ç£ããªãã£ãããšããšã³ãã«ã¹ãNIHã«ãå±éºãªå®éšã驿ã«å ±åãããªãã£ãããšãªã©ãNIHãšãšã³ãã«ã¹ã«ããè€æ°ã®ã倱æããæããŠããã
HHSã¯5æãå§å¡äŒãéå¶å©å£äœãNIH婿éã®æ¡ä»¶ã«éåãããšãã蚌æ ãå ¬è¡šããåŸããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ã®æ¿åºå©æéã忢ããã
2.ç§åŠçæ ¹æ ã«åºã¥ããªãé·æäŒæ ¡ãããã¯ããŠã³
åŠæ ¡ãééããé·æã«ããã£ãŠééãç¶ããããšã¯ãå©çšå¯èœãªç§åŠãšèšŒæ ã«è£ä»ããããŠããªããå ±åæžã¯ãäžåœæŠæŒ¢ã®åæã®ããŒã¿ãããåã©ããã¡ãCOVID-19ã«ãã£ãŠé節ãªç æ°ã«ãªã£ããæ»äº¡ãããããå¯èœæ§ã¯äœãããšã瀺ããããšææããã
ããã¯åŸã«ç±³åœçŸç äºé²ç®¡çã»ã³ã¿ãŒã«ãã£ãŠç¢ºèªããã2020幎3æ1æ¥ãã2020幎7æ25æ¥ã®éã®COVID-19ã«ããå ¥é¢æ£è ã®0.01ïŒ æªæºãæ»äº¡è ã®0.0005ïŒ æªæºãåã©ãã§ãããšå ±åãããã
å ±åæžã¯ãŸããåŠæ ¡ééãCOVID-19ã®èå»¶ãç·©åããå¯èœæ§ã¯äœããšããããŒã¿ãåŒçšããŠããããç§åŠçã«ã¯ãåŠæ ¡ã¯ãŠã€ã«ã¹æ¡æ£ã®åªä»ç©ã§ã¯ãªãããšå ±åæžã¯è¿°ã¹ãŠããã
å ±åæžã¯ãŸããåŠæ ¡éé以å€ã®ããã¯ããŠã³ã®åãçµã¿ãç§åŠç蚌æ ã«è£ä»ããããŠããªãããšãè«ãããããã¯ããŠã³ã¯äžå¿ èŠã«ç±³åœã®äŒæ¥ãåžæ°ãç¹ã«åäŸãã¡ãå·ã€ããã
3.ãã¡ãŠãã¯ãã6ãã£ãŒãééãã®æšå¥šã¯ããã çŸããã ãããšè¿°ã¹ãã
ãã¹ã¯ççšãšç€ŸäŒçè·é¢ã®æšå¥šã¯ãCOVID-19ã®èå»¶æå¶ã«åœ¹ç«ã€ãšããæ±ºå®çãªèšŒæ ãæ¬ ããŠããã
ãã³ãããã¯ã®éãå ¬è¡è¡çåœå±ã¯ç§åŠçããŒã¿ãæäŸããããšãªãããã¹ã¯ã®æå¹æ§ã«ã€ã㊠ãæã®ã²ããè¿ãã ããšåœŒãã¯ææãããå ±åæžã«ããã°ã2æ³ä»¥äžã®å¹Œå ã«åŒ·å¶çã«ãã¹ã¯ããããããšã¯ããçããã害ããããããããšããã
ãã¡ãŠãã¯éå ¬éã®èšŒèšã®äžã§ã6ãã£ãŒãïŒçŽ1.5ã¡ãŒãã«ïŒé¢ããšãã瀟äŒçè·é¢ã眮ãæå°ã ããã çŸãã ããšè¿°ã¹ãã
4.ç±³åœæ¿åºã¯COVIDã¯ã¯ãã³ã§è² å·ãã人ã ã倱æãããŠãã
å§å¡äŒã®ã¡ã³ããŒã¯ãCICPïŒCOVID-19ã®æ¥çš®ã«ãã£ãŠè² å·ãã人ã ã«å¯Ÿå¿ããããã®æ¿åºã®ä»çµã¿ïŒãã©ã®çšåºŠæ©èœããŠããããåæããã
圌ãã¯ãCICPã¯ãCOVID-19ã¯ã¯ãã³ã«ããè² å·ã«å¯Ÿããè³ åè«æ±ããå¹ççãå ¬æ£ããã€éææ§ããã£ãŠè£å®ããããšã«å€±æããŠããããšçµè«ã¥ãããCICPã¯HHSã®äžã§éå¶ãããŠããã
匷åºã§éææ§ã®ãããã¯ã¯ãã³å·å®³è£åããã°ã©ã ã®æ§ç¯ãå¿ èŠã§ãããå ±åæžã¯ãã説æããŠããïŒ
ãCOVID-19ã¯ã¯ãã³ãç¹ã«å±éºã§ãããšãã䞻匵ã«ããããããé£éŠæ¿åºã¯ãCOVID-19ã¯ã¯ãã³ãåŒãèµ·ããäžå¯é¿ã®å·å®³ãè£å®ããé©åãªã·ã¹ãã ãæŽåããªããŸãŸãCOVID-19ã¯ã¯ãã³ã®æ¥çš®ã矩åä»ããããã§ããããã®ããšã¯ãåœæ°ã®ä¿¡é Œã«é倧ãªåœ±é¿ãåãŒããã¯ã¯ãã³ã«å¯Ÿããä¿¡é Œãæãªãå¯èœæ§ããããã
å ±åæžã®èè ã¯ãã¯ã¯ãã³ã«ããå·å®³ã«ã€ããŠè°è«ããããšã¯ ãåã¯ã¯ãã³ ãã§ã¯ãªããšè¿°ã¹ãŠãããç¹ã«COVID-19ã¯ã¯ãã³ã§è² å·ãã人㫠ãåã¯ã¯ãã³ ããšããã¬ããã«ã貌ãã®ã¯é説çã§ããã
ããã®åè£çãªè¡šçŸã¯ãCOVID-19ã¯ã¯ãã³æ¥çš®ãã£ã³ããŒã³ã®æ±ºå®çãªèª€ãã§ãã£ãã"ããã¯ããŸãã§ã¯ããããã¯ã¯ãã³ã«ãã£ãŠäººçãå€ãããããªå¯åå¿ãçµéšãã人ã ãçå€ããæé€ããã
5.HHSã¯èšŒæ ãé èœãã
ãã€ãã³æ¿æš©ã®HHSè·å¡ã¯ããå ¬è¡è¡çã®é«å®ãæçœªã«ããããå°æããããããå¯èœæ§ã®ãã蚌æ ãæ æã«é£èªåããããã¬ã¹ãªãªãŒã¹ã«ããã°
ããã€ãã³æ¿æš©ã®HHSã¯ãç¹å¥å°å§å¡äŒã®èª¿æ»ã劚害ããå ¬è¡è¡çã®é«å®ãæçœªã«ãããå°æãããããã蚌æ ãé èœããããšãæ°å¹Žã«ãããé å»¶ãæ··ä¹±ãç¡åå¿ã®ãã£ã³ããŒã³ãè¡ã£ããã
ãHHSã¯ãç«æ³åºã®ç£èŠèŠæ±ã«å¯Ÿå¿ããéšéã®äººå¡ããæå³çã«äžè¶³ãããŠããããã ãã
å ±åæžã¯ãäžå®å šã§ãã£ãããé床ã«ç·šéãããHHSã®ææžã®ç»åã瀺ããã
6.ãã¡ãŠãã®äžçŽé¡§åã蚌æ é æ» ãè¡ã£ã
å ±åæžã¯40ããŒãžä»¥äžãå²ããŠãããŒãããã»ã¢ãŒã³ãºå士ãããã« ã蚌æ ãé æ» ãã説æè²¬ä»»ããéããããã«å人çãªé»åã¡ãŒã«ã䜿çšããé£éŠè·å¡ãšããŠãµãããããªãè¡åããšã£ãã ãã詳述ããã
å§å¡äŒã¯ããã¡ãŠãã®é·å¹Žã®åŽè¿ã§ãã£ãã¢ãŒã³ãºãããã¡ãŠããšãã¹ã¶ãã¯ãšã®éã®ã¡ãã»ãŒãžãå«ãã圌ã®å人çãªGmailã¢ã«ãŠã³ãããã®æ©å¯ã¡ãŒã«ãç Žæ£ãããšäž»åŒµããã
å§å¡äŒãå ¥æããã¡ã¢ãš150é以äžã®é»åã¡ãŒã«ã«ãããšãã¢ãŒã³ãºã¯æ å ±å ¬éæ³ïŒFOIAïŒ-é£éŠæ¿åºæ©é¢ã®èšé²ã¯ãéãããäŸå€ãé€ããèŠæ±ã«å¿ããŠäžè¬ã«æäŸãããããšã矩åã¥ããæ³åŸ-ãåé¿ããããã«ãããªãã®æéãšãšãã«ã®ãŒãè²»ãããŠããã
æ©å¯ã¡ãŒã«ãåé€ããã ãã§ãªããã¢ãŒã³ãºã¯æ å ±å ¬é宀ã®NIAID管çè ãšååããŠãäžè¬åžæ°ãæ€çŽ¢ãèŠæ±ããå¯èœæ§ã®ããããŒã¯ãŒãã®ã¹ãã«ãæŠç¥çã«ééããããšå§å¡äŒã¯äž»åŒµããŠããã
å§å¡äŒã¯ãã¬ã¹ãªãªãŒã¹ã®äžã§ãã¢ãŒã³ãºã¯äœåºŠãè°äŒã«å¯ŸããŠãåãã€ããå¯èœæ§ãé«ãããšããé£éŠæ¿åºã®COVID-19ã®èšé²ãéæ³ã«åé€ããNIHã®å©æéããã»ã¹ã«é¢ããéå ¬éæ å ±ããã¶ãã¯ãšå ±æãããšè¿°ã¹ãã
7.ãã¶ãã¯ãå°å§å¡äŒãã蚌æ ãé ãããšãã
ããã10ããŒãžã«ããã£ãŠããã¹ã¶ãã¯ãšãšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ãå§å¡äŒã®èª¿æ»ã劚害ããããŸããŸãªæ¹æ³ã詳述ãããŠããã
äŸãã°ããã¹ã¶ãã¯ã¯æ å ±æäŸãé¿ããããšãããå ±åæžã«ã¯ããããïŒ
ãã¶ãã¯å士ãšWHOïŒäžçä¿å¥æ©é¢ïŒèµ·æºã®èª¿æ»ã¡ã³ããŒã§ããããªãªã³ã»ã¯ãŒããã³ãºå士ãšã®éã®ææžããã³éä¿¡ã«å¯Ÿããç¹å¥å°å§å¡äŒã®èŠæ±ã«å¯ŸããŠããã¶ãã¯å士ã¯ããå€äº€ç¹æš© ããš ãWHOã®ãã©ã€ãã·ãŒèŠå ãã䞻匵ããããšã«ãã£ãŠãç¹å¥å°å§å¡äŒã劚害ããããšãèšç»ããã
ãã¹ã¶ãã¯ã¯ãŸããå¶äœã®ç¯å²ãšããŒã¹ãçž®å°ããããã¹ã¿ããã«æç€ºãããå°å§å¡äŒããšã³ãã«ã¹ã®ææžãå¬åãããšè ããåŸããã¹ã¶ãã¯ã¯ããæžãããã圌ããç§ãã¡ã®ææžäœæã«åé¡ããããšæžããŠããããç§ãã¡ã¯æ¥éã«å€ãã®ææžãäœæãããããå³ ãè¶ãããšããã ãããã
å§å¡äŒã¯ããã¹ã¶ãã¯æ°ã®èšŒèš-ãæžãèµ·ããããã€ã³ã¿ãã¥ãŒãšå ¬èŽäŒã®äž¡æ¹ã«ãããŠã-ãšå ¥æå¯èœãªææžãšãæ¯èŒããããããŠãããã¹ã¶ãã¯å士ãç¹å¥å°å§å¡äŒã«èåœã®èšŒèšãããå¯èœæ§ãé«ãããšçµè«ã¥ããã